Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
BEAM
ACCE ResearchedBeam Therapeutics Inc. Common Stock
HealthcareBiotechnologyNASDAQ
$30.70
+1.22%today
MKT CAP
$3.2B
NEXT EARNINGS
Feb 24
Analysis in progress.
+54.9% · 1Y
Get the ACCE weekly digest
Index returns, picks recap, score movers — every Sunday. No fluff.